Merck Historical Income Statement
| MRK Stock | USD 103.11 1.49 1.47% |
Historical analysis of Merck income statement accounts such as Gross Profit of 46.2 B can show how well Merck Company performed in making a profits. Evaluating Merck income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Merck's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Merck Company latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Merck Company is a good buy for the upcoming year.
Merck |
About Merck Income Statement Analysis
Merck Company Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Merck shareholders. The income statement also shows Merck investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Merck Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Merck Company generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Merck Company minus its cost of goods sold. It is profit before Merck operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Merck Company. It is also known as Merck overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Merck Company operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Merck Company is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Merck's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Merck Company current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Merck's EBITDA is quite stable compared to the past year. Total Operating Expenses is expected to rise to about 46.2 B this year, although the value of Cost Of Revenue will most likely fall to about 11.7 B.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 35.1B | 41.9B | 44.0B | 46.2B | Total Revenue | 48.7B | 59.3B | 60.1B | 32.4B |
Merck income statement Correlations
Click cells to compare fundamentals
Merck Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Merck income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 3.7B | 3.5B | 3.2B | 3.9B | 3.9B | 2.8B | |
| Interest Expense | 893M | 831M | 806M | 962M | 1.1B | 1.2B | |
| Total Revenue | 46.8B | 41.5B | 48.7B | 59.3B | 60.1B | 32.4B | |
| Gross Profit | 32.7B | 27.9B | 35.1B | 41.9B | 44.0B | 46.2B | |
| Other Operating Expenses | 34.6B | 36.0B | 35.5B | 41.0B | 57.2B | 60.0B | |
| Operating Income | 9.2B | 6.1B | 13.7B | 19.4B | 3.0B | 5.6B | |
| Ebit | 9.2B | 6.7B | 14.7B | 17.4B | 3.0B | 5.6B | |
| Ebitda | 12.9B | 10.2B | 17.9B | 21.3B | 6.9B | 8.4B | |
| Cost Of Revenue | 14.1B | 13.6B | 13.6B | 17.4B | 16.1B | 11.7B | |
| Total Operating Expenses | 20.5B | 22.4B | 21.9B | 23.6B | 44.0B | 46.2B | |
| Income Before Tax | 11.5B | 8.8B | 13.9B | 16.4B | 1.9B | 1.8B | |
| Total Other Income Expense Net | 2.2B | 315M | 680M | (1.8B) | (1.1B) | (1.0B) | |
| Net Income | 9.8B | 7.1B | 13.0B | 14.5B | 365M | 346.8M | |
| Income Tax Expense | 1.7B | 1.7B | 1.5B | 1.9B | 1.5B | 2.0B | |
| Research Development | 9.9B | 13.4B | 12.2B | 13.5B | 30.5B | 32.1B | |
| Selling General Administrative | 8.7B | 7.2B | 7.6B | 7.8B | 8.2B | 8.7B | |
| Net Income Applicable To Common Shares | 9.8B | 7.1B | 13.0B | 14.5B | 16.7B | 17.5B | |
| Minority Interest | (66M) | 15M | 691M | (7M) | (13M) | (12.4M) | |
| Net Income From Continuing Ops | 9.8B | 7.1B | 12.4B | 14.5B | 4.6B | 8.0B | |
| Non Recurring | 638M | 578M | 661M | 337M | 303.3M | 288.1M | |
| Non Operating Income Net Other | (139M) | 886M | 1.3B | (1.5B) | (1.4B) | (1.3B) | |
| Selling And Marketing Expenses | 1.9B | 1.8B | 2B | 2.2B | 2.3B | 2.2B | |
| Tax Provision | 1.7B | 1.7B | 1.5B | 1.9B | 2.8B | 2.2B | |
| Interest Income | 274M | 59M | 1.9B | 1.3B | 390M | 732.6M | |
| Net Interest Income | (619M) | (772M) | (770M) | (805M) | (681M) | (715.1M) | |
| Reconciled Depreciation | 3.7B | 3.6B | 3.2B | 3.9B | 3.8B | 3.1B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Dividend Share 3.04 | Earnings Share 4.78 | Revenue Per Share 24.931 | Quarterly Revenue Growth 0.044 |
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.